1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. PI4K

PI4K (磷脂酰肌醇4激酶)

Phosphatidylinositol 4 kinases; PI4 kinases

Phosphatidylinositol 4-kinases (PI4Ks) catalyze the synthesis of phosphatidylinositol 4-phosphate (PI4P), an important intermediate for the synthesis of membrane polyphosphoinositides, regulators of multiple cellular functions. PI4P defines the membranes of Golgi and trans-Golgi network (TGN) and regulates trafficking to and from the Golgi. Based on enzymatic differences, two classes of PI4K have been distinguished termed Types II (PI4KII) and III (PI4KIII), and each of which contains α and β isoforms.

PI4KII alpha and beta have similar biochemical properties. PI4KIIIs (α- and β-forms) are soluble enzymes structurally related to PI3-kinases, and sensitive to PI3-kinase inhibitors, such as Wortmannin. PI4KIIs produce PtdIns 4-phosphate, an early key signaling molecule in phosphatidylinositol cycle, which is indispensable for T cell activation. PI4KIIIs plays a key role in the production of replication complexes (viral factories) of a number of positive-sense RNA viruses and represents a potential target for novel pan-viral therapeutics.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-110248
    MI 14 Inhibitor 99.30%
    MI 14 是一种选择性 PI4KIIIβ 抑制剂,对 PI4KIIIβ、PI4KIIIα、PI4KIIα 的 IC50 分别为 54 nM、>100 μM、>100 μM。MI 14 对 HCV 1b、CVB3、HRVM、HVC 2a 具有抗病毒活性。
    MI 14
  • HY-161357
    KR-27370 Inhibitor
    KR-27370 (compound 7f) 是一种抗病毒剂和选择性的 PI4KIIIβ/PI4KIIIα 抑制剂 (IC50: 3.1 nM/15.8 nM),对 hRV、柯萨奇病毒和其他肠道病毒具有抑制活性[1].br/
    KR-27370
  • HY-156685
    EDI048 Inhibitor
    EDI048 (化合物1.16) 是一种口服有效的 Cryptosporidium PI4K 抑制剂,可用于隐孢子虫病的研究。
    EDI048
  • HY-148075
    PI4KIIIbeta-IN-11 Inhibitor
    PI4KIIIbeta-IN-11 是 PI4KIIIβ 抑制剂,平均 pIC50 为 9.1。PI4KIIIβ 在 RNA 病毒和恶性疟原虫引起的疾病研究中具有重要作用。
    PI4KIIIbeta-IN-11
  • HY-118525
    AL-9 Inhibitor
    AL-9 是 PI4KIIIα 抑制剂,IC50 为 0.57 μM,可抑制 HCV 复制。
    AL-9

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.